OOIR: Observatory of International Research

Papers

(The median citation count of Pharmacological Reviews is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
The Role of G Protein–Coupled Receptors and Receptor Kinases in Pancreatic β-Cell Function and Diabetes	418
Seventy-Five Years of Interactions: The Department of Physiology and Pharmacology at Karolinska Institutet and Pharmacological Reviews	412
Innovative therapeutics for renoprotection: Where we are	252
Reimagining pharmacology education	201
The Nitrogen Mustards	178
Review of Natural Language Processing in Pharmacology	155
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics	146
Carbonic anhydrase inhibitors: “Old” drugs with new potential in unexpected areas	136
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapies	123
Table of Contents	119
Table of Contents	118
Metal-based antibody, nanobody, and peptide conjugates: Potential for breast cancer therapy	110
Table of Contents	106
The endocannabinoidomes: Pharmacological redundancy and promiscuity, and multi-kingdom variety of sources and molecular targets	106
Innovation in cancer pharmacotherapy through integrative consideration of germline and tumor genomes	100
Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems	100
Optical Approaches for Investigating Neuromodulation and G Protein–Coupled Receptor Signaling	90
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer	79
Elucidating the Interactome of G Protein-Coupled Receptors and Receptor Activity-Modifying Proteins	78
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023	74
Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases	69
Targeting of kinases to treat neurodegenerative diseases	69
Table of Contents	67
Therapeutic Potential of Targeting Prokineticin Receptors in Diseases	66
Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications	65

miR-155 aberrant expression impairs tumor rejection because of its targeting of ICOSL and multiple pathways implicated in the antitumor response	60
G Protein-Coupled Receptor Pharmacology—Insights from Mass Spectrometry	59
Asthma therapeutics: Past, present, and future	58
Carbon Monoxide Signaling: Examining Its Engagement with Various Molecular Targets in the Context of Binding Affinity, Concentration, and Biologic Response	57
Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism	54
The Hippo pathway: Organ size control and beyond	54
Corrigendum to “International Union of Basic and Clinical Pharmacology. CXIX. Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes” [Pharmacologic	53
Nonhormonal Male Contraceptive Development—Strategies for Progress	52
Sulfotransferase 2B1b, Sterol Sulfonation, and Disease	52
Targeting Persistent Changes in Neuroimmune and Epigenetic Signaling in Adolescent Drinking to Treat Alcohol Use Disorder in Adulthood	51
From neuroimmune circuits to targeted therapy of chronic pruritus	51
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy	50
Neurobiology of the incubation of drug craving: An update	50
Dopamine, Immunity, and Disease	49
Disulfidptosis: A novel cell death mechanism with pathological significance and therapeutic potential in diseases	48
Editorial Board	47
Pharmacological Reviews’ 75th Year Anniversary: Past and Future—Editorial	44
Extracellular Vesicle Heterogeneity and Its Impact for Regenerative Medicine Applications	43
Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks	43
Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting	42
Animal Behavior in Psychedelic Research	42
Conotoxins Targeting Voltage-Gated Sodium Ion Channels	42
Effects of Medications on Heat Loss Capacity in Chronic Disease Patients: Health Implications Amidst Global Warming	41
Vitamin D and its analogs in immune system regulation	40
Table of Contents	37
Pharmacological strategies to bridge the gap between cancer and cardiovascular therapeutics	34
The Development of Cannabinoids as Therapeutic Agents in the United States	33
International Union of Basic and Clinical Pharmacology. CXVIII. Update on the nomenclature for atypical chemokine receptors, including ACKR5	33
Erratum to “Advances and challenges in experimental models of posttraumatic epilepsy for therapeutic interventions” [Pharmacological Reviews 77 (2025) 100080]	33
Harnessing multiomics technologies and machine learning for advancing personalized theranostic approaches in atherosclerosis	32
Epithelial cells in chronic obstructive pulmonary disease exacerbations: Targets for lung repair	32
Time to Change: A Systems Pharmacology Approach to Disentangle Mechanisms of Drug-Induced Mitochondrial Toxicity	30
Drugging dancing protein clouds: A close look at disorder-based drug design	30
Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment	30
Table of Contents	28
Table of Contents	28
Anticoagulants: From chance discovery to structure-based design	27
The complement system: Biology, pathology, and therapeutic interventions	26
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy	25
Adrenoceptor Desensitization: Current Understanding of Mechanisms	24
Synergistic combinations of antimicrobial peptides and conventional antibiotics: A strategy to delay resistance emergence in World Health Organization priority bacteria	24
Modeling lung transporters and their influence on inhaled drug disposition	23
Carbon dots for drug delivery: Insights into their potential in nanopharmacology	23
Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis	22
From bone sentinel to immune savant: Vitamin D and its receptor’s pharmacology	22
International Union of Basic and Clinical Pharmacology. CXX. γ-Hydroxybutyrate protein targets in the mammalian brain—beyond classic receptors	22
Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance	22
Antipsychotics and dietary interventions: Pharmacodynamics, pharmacokinetics, and synergisms in therapy	22
Targeting Epidermal Growth Factor Receptor for Cancer Treatment: Abolishing Both Kinase-Dependent and Kinase-Independent Functions of the Receptor	21
Pharmacological Regulation of Endoplasmic Reticulum Structure and Calcium Dynamics: Importance for Neurodegenerative Diseases	21

Analyzing lognormal data: A nonmathematical practical guide	21
Pharmacological Approaches to Hearing Loss	21
International Union of Basic and Clinical Pharmacology CXV: The Class F of G Protein-Coupled Receptors	21
Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates	21
The evolution of lipid-lowering drugs in the management of cardiovascular disease risk: From the first cardiovascular disease risk–reducing therapies to the novel challenging strategies	21
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application	20
Summing Up Pharmacological Reviews’ 75th Anniversary Year and a Look to the Future	20
Pharmacology and Precision Medicine—Preparing for the Next Era in Clinical Medicine—Editorial	19
Pharmacological therapies for male infertility	19
Lymphocyte Depleting and Modulating Therapies for Chronic Lung Allograft Dysfunction	18
Leveraging Lymphatic System Targeting in Systemic Lupus Erythematosus for Improved Clinical Outcomes	17
Changing Cerebral Blood Flow, Glucose Metabolism, and Dopamine Binding Through Transcranial Magnetic Stimulation: A Systematic Review of Transcranial Magnetic Stimulation-Positron Emission Tomography	17
Senotherapy for chronic lung disease	16
Emergence of Extracellular Vesicles as “Liquid Biopsy” for Neurological Disorders: Boom or Bust	16
A 25-Year Journey as Author and Associate Editor of Pharmacological Reviews—Editorial	15
A Chance to Grow and Excel as an Associate Editor of Pharmacological Reviews—Editorial	15
Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies	14
Thrombin Generation and the Pharmacodynamics of Parenteral Anticoagulants	14
Fibroblasts—The emerging therapeutic target of the cardiovascular system?	14
Editorial Board	14
Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future	13
Pharmacologic treatments for gastroparesis	13
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials	13
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain	12
Prostaglandin E2 in the Tumor Microenvironment, a Convoluted Affair Mediated by EP Receptors 2 and 4	12
International Union of Basic and Clinical Pharmacology. CXVII: Taste 2 receptors—Structures, functions, activators, and blockers	12
Multi- and polypharmacology of carbonic anhydrase inhibitors	12
Bioactives from marine resources as natural health products: A review	11
Cellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies	11
Ferroptosis and pathogenesis of neuritic plaques in Alzheimer disease	11
Cyclic nucleotide phosphodiesterases as drug targets	10
Reversing the odds: Advanced and emerging therapeutic strategies for male infertility	10
Cytochrome P450 Enzymes: The Old Pandora’s Box with an Ever-Growing Hope for Therapy Optimization and Drug Development—Editorial	10
Platelet activation, aspirin, and cancer: From basic science to clinical trials	10
Table of Contents	10
Pharmacological modulation of the blood-brain barrier: Mechanisms, therapeutic strategies, and emerging technologies	9
Corrigendum to “Cell cycle dysregulation in cancer” [Pharmacological Reviews 77 (2025) 100030]	9
Links between COVID-19, long COVID, and neurodegeneration: The role of glycosphingolipids	9
Nitric Oxide Signaling and Regulation in the Cardiovascular System: Recent Advances	9
Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options	9
From physiopathology to treatment of familial hypercholesterolemia: Existing and emerging pharmacotherapies	9
The neuropharmacological basis of placebo analgesia: Mechanisms and clinical applications in the context of chronic pain	8
Table of Contents	8
International Union of Basic and Clinical Pharmacology CXIV: Orexin Receptor Function, Nomenclature and Pharmacology	8
Erratum to “Edaravone: Advances on cytoprotective effects, pharmacological properties, and mechanisms of action” [Pharmacological Reviews 78 (2025) 100101]	8
Physiological functions and pharmacological targeting of transient receptor potential channels	8
Generation of Comprehensive GPCR-Transducer-Deficient Cell Lines to Dissect the Complexity of GPCR Signaling	8
Pharmacological Targeting of Mitochondria in Diabetic Kidney Disease	8
Genetic therapies for neurological diseases	7
Editorial Board	7
Application of Kirchhoff’s Laws to pharmacologic and pharmacokinetic analyses	7
Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction	7
Toward a paradigm shift: Oral agents and injectable drugs in the future of obesity management	7
Editorial Board	7
Neuropeptides as transmitters and regulators of the locus coeruleus noradrenergic system	7
Hepatic Bile Formation: Developing a New Paradigm	6
Prospects for the convergence of polyphenols with pharmaceutical drugs in type 2 diabetes: Challenges, risks, and strategies	6
How dopamine guides our social world	6
Immunomodulatory effects of calorie restriction and its mimetics: A new potential therapeutic approach for autoimmune diseases	6
Editorial Board	6
Waking up to the evidence of pharmacological treatments used to manage sleep disorders in people with dementia and mild cognitive impairment—A scoping review	6
Immunomodulatory and Anti-Cancer Effects of Phytochemicals: A Comprehensive Analysis	6